These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15277312)

  • 1. Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.
    Schram G; Zhang L; Derakhchan K; Ehrlich JR; Belardinelli L; Nattel S
    Br J Pharmacol; 2004 Aug; 142(8):1300-8. PubMed ID: 15277312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
    Antzelevitch C; Belardinelli L; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Thomas G
    Circulation; 2004 Aug; 110(8):904-10. PubMed ID: 15302796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentamidine-induced long QT syndrome and block of hERG trafficking.
    Kuryshev YA; Ficker E; Wang L; Hawryluk P; Dennis AT; Wible BA; Brown AM; Kang J; Chen XL; Sawamura K; Reynolds W; Rampe D
    J Pharmacol Exp Ther; 2005 Jan; 312(1):316-23. PubMed ID: 15340016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent.
    Antzelevitch C; Belardinelli L; Wu L; Fraser H; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Goodrow RJ; Scornik F; Perez G
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S65-83. PubMed ID: 15378132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
    Antoons G; Oros A; Beekman JD; Engelen MA; Houtman MJ; Belardinelli L; Stengl M; Vos MA
    J Am Coll Cardiol; 2010 Feb; 55(8):801-9. PubMed ID: 20170820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
    Jia S; Lian J; Guo D; Xue X; Patel C; Yang L; Yuan Z; Ma A; Yan GX
    Br J Pharmacol; 2011 Sep; 164(2):308-16. PubMed ID: 21182492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine.
    Choi SY; Koh YS; Jo SH
    J Pharmacol Exp Ther; 2005 May; 313(2):888-95. PubMed ID: 15722405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5--sildenafil, tadalafil, and vardenafil.
    Dustan Sarazan R; Crumb WJ; Beasley CM; Emmick JT; Ferguson KM; Strnat CA; Sausen PJ
    Eur J Pharmacol; 2004 Oct; 502(3):163-7. PubMed ID: 15476742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
    Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid kinetic interactions of ranolazine with HERG K+ current.
    Rajamani S; Shryock JC; Belardinelli L
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):581-9. PubMed ID: 18520952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of the anti-cancer drug lapatinib on cardiac repolarization.
    Lee HA; Kim EJ; Hyun SA; Park SG; Kim KS
    Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):614-8. PubMed ID: 20406211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antipsychotic drug chlorpromazine inhibits HERG potassium channels.
    Thomas D; Wu K; Kathöfer S; Katus HA; Schoels W; Kiehn J; Karle CA
    Br J Pharmacol; 2003 Jun; 139(3):567-74. PubMed ID: 12788816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ; Robertson C; Dhalla AK; Belardinelli L
    J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
    Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
    Song Y; Shryock JC; Wu L; Belardinelli L
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):192-9. PubMed ID: 15243300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common antitussive drug, clobutinol, precipitates the long QT syndrome 2.
    Bellocq C; Wilders R; Schott JJ; Louérat-Oriou B; Boisseau P; Le Marec H; Escande D; Baró I
    Mol Pharmacol; 2004 Nov; 66(5):1093-102. PubMed ID: 15280442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of AMP 579, a novel cardioprotective adenosine A1/A2A receptor agonist, on native IKr and cloned HERG current.
    Saegusa N; Sato T; Ogura T; Komuro I; Nakaya H
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):492-9. PubMed ID: 15558241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model.
    Sossalla S; Wallisch N; Toischer K; Sohns C; Vollmann D; Seegers J; Lüthje L; Maier LS; Zabel M
    Cardiovasc Ther; 2014 Aug; 32(4):170-7. PubMed ID: 24785406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.